Viewing Study NCT00372892


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-26 @ 7:24 PM
Study NCT ID: NCT00372892
Status: COMPLETED
Last Update Posted: 2012-06-07
First Post: 2006-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Sponsor: Hamilton Health Sciences Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module